Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats-Reference-Cited by-同舟云学术

Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats

Published:2011-09-05 Issue:2 Volume:42 Page:206-219
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Bertera Facundo,Di Verniero Carla Andrea,Mayer Marcos Alejandro,Chiappetta Diego,Buontempo Fabián,Polizio Ariel Héctor,Taira Carlos Alberto,Höcht Christian

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/00498254.2011.604746

Reference46 articles.

1. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation

2. Pharmacological characteristics of the stereoisomers of carvedilol

3. Is urethane–chloralose anaesthesia appropriate for pharmacokinetic–pharmacodynamic assessment? Studies with carvedilol

4. Increased sensitivity to diltiazem hypotensive effect in an experimental model of high-renin hypertension

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced Efficacy of Carvedilol by Utilization of Solid Dispersion and Other Novel Strategies: A Review;Cardiovascular & Hematological Disorders-Drug Targets;2023-09

2. An Integrative Approach for Improved Assessment of Cardiovascular Safety Data;Journal of Pharmacology and Experimental Therapeutics;2021-03-01

3. MODERN APPLICATION OF BETA-ADRENOBLOCKER IN PHARMACOTHERAPY OF CHRONIC HEART FAILURE AMONG PATIENTS WITH ISCHEMIC HEART DISEASE;INDO AM J PHARM SCI;2018

4. What is the Real Efficacy of Beta-Blockers for the Treatment of Essential Hypertension?;Current Pharmaceutical Design;2017-12-04

5. Effects of carvedilol or amlodipine on target organ damage in L-NAME hypertensive rats: their relationship with blood pressure variability;Journal of the American Society of Hypertension;2017-04